Compare BHC & ARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BHC | ARR |
|---|---|---|
| Founded | N/A | 2008 |
| Country | US | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.0B |
| IPO Year | 1996 | N/A |
| Metric | BHC | ARR |
|---|---|---|
| Price | $5.97 | $17.57 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $8.67 | ★ $18.17 |
| AVG Volume (30 Days) | 2.2M | ★ 3.3M |
| Earning Date | 05-18-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 16.29% |
| EPS Growth | ★ 423.08 | N/A |
| EPS | ★ 0.42 | N/A |
| Revenue | ★ $8,724,000,000.00 | N/A |
| Revenue This Year | $6.67 | $296.22 |
| Revenue Next Year | $4.23 | $99.47 |
| P/E Ratio | ★ $8.66 | $27.18 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.28 | $13.18 |
| 52 Week High | $8.69 | $19.31 |
| Indicator | BHC | ARR |
|---|---|---|
| Relative Strength Index (RSI) | 44.48 | 44.87 |
| Support Level | $5.83 | $17.03 |
| Resistance Level | $6.25 | $18.61 |
| Average True Range (ATR) | 0.24 | 0.45 |
| MACD | 0.07 | -0.02 |
| Stochastic Oscillator | 61.64 | 34.38 |
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
ARMOUR Residential REIT Inc operate in the U.S. and invest in fixed rate residential, adjustable rate and hybrid adjustable rate residential MBS issued or guaranteed by U.S. GSEs or guaranteed by Ginnie Mae. It also invest in U.S. Treasury Securities and money market instruments.